Epristeride
Alternative Names: Aipuliete™; ONO 9302; SKF 105657Latest Information Update: 08 Jul 2023
At a glance
- Originator GlaxoSmithKline
- Developer China Pharmaceutical University; Jiangsu Lianhuan Pharmaceutical; Ono Pharmaceutical
- Class Androstadienes; Antihormones; Small molecules
- Mechanism of Action Cholestenone 5 alpha-reductase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Marketed Benign prostatic hyperplasia
- Discontinued Acne; Alopecia; Cancer
Most Recent Events
- 15 Apr 2000 Launched for Benign prostatic hyperplasia in China (unspecified route)
- 23 Mar 1999 Discontinued-Preclinical for Acne in USA (Unknown route)
- 23 Mar 1999 Discontinued-Preclinical for Alopecia in USA (Unknown route)